港交所新股轩竹生物上市首日高开153.97%
XUANZHUBIO-BXUANZHUBIO-B(HK:02575) Bei Jing Shang Bao·2025-10-15 01:45

Core Viewpoint - XuanZhu Bio (02575.HK) debuted on the Hong Kong Stock Exchange on October 15, 2023, with a significant opening increase of 153.97%, starting at a price of HKD 29.46 per share [1] Company Overview - XuanZhu Bio is an innovative pharmaceutical company with over ten drug assets actively under development, targeting diseases related to the digestive system, tumors, and non-alcoholic fatty liver disease [1] - The company's core product, KBP-3571, is an innovative drug developed in-house, specifically for the treatment of duodenal ulcers [1]